Ana Krtolica, Ph.D., CEO, CSO
Dusko Ilic, M.D. Ph.D.
Eduardo J. Caceres, B.S.
Chief Executive Officer
Ana Krtolica, Ph.D., CEO, CSO Member, Board of Directors
Ana Krtolica Ph.D., cofounder, CEO and chief scientific officer (CSO), formed StemLifeLine in 2005 to offer individuals who have undergone in vitro fertilization a unique option to develop stem cell lines from their remaining stored embryos. As an expert in the development of appropriate microenvironments for cell culture and embryonic stem cell derivation, Dr. Krtolica oversees all scientific processes at StemLifeLine, including the derivation and cultivation of stem cell lines.
Prior to establishing StemLifeLine, Dr. Krtolica held a joint appointment as a career scientist at Lawrence Berkeley National Laboratory and at the University of California, San Francisco. She has published more than 20 research papers in peer-reviewed journals, is a member of the editorial board of Regenerative Medicine and has written two book chapters for Stem Cells in Reproductive Medicine and Current Protocols in Stem Cell Biology. Dr. Krtolica recently co-authored a study on human embryonic stem cell derivation using human feeders with Olga Genbacev, Ph.D., President of the Executive Board of StemLifeLine. Dr. Krtolica’s other professional activities include teaching courses for California’s Buck institute and the National Institutes of Health at Stanford University, in Palo Alto, California and University of Pittsburg in Pennsylvania.
Dr. Krtolica received her Ph.D. in biochemistry and master’s degree from the University of Rochester, New York.
Management
Dusko Ilic, M.D. Ph.D. Director, Research and Development
Dusko Ilic, M.D., Ph.D., director, Research and Development for StemLifeLine, works closely with Dr. Krtolica and is directly responsible for management of stem cell derivation and scientific development. An internationally recognized scientist, he brings extensive experience in embryonic stem cell manipulation with specific expertise on the role of extracellular matrix in basic cellular functions.
Prior to joining StemLifeLine, Dr. Ilic held research and teaching positions at the University of California, San Francisco’s Department of Cell & Tissue Biology. Dr. Ilic has authored more than 30 published articles and recently co-authored a chapter on embryonic stem cell derivation in the book Current Protocols in Stem Cell Biology with StemLifeLine founders Ana Krtolica and Olga Genbacev. Dr. Ilic writes monthly updates on advances in stem cell research for the peer-reviewed journal, Regenerative Medicine.
Dr. Ilic holds an M.D. and a master’s degree from the University of Belgrade, Yugoslavia. He completed his Ph.D. in developmental genetics at the University of Tokyo, Japan, where he was awarded a prestigious graduate student scholarship on behalf of the Ministry of Education, Science and Culture of Japan. He was also the recipient of the National Institute of Health/National Institute of Cancer Howard Temin Award (2000-2005), the Hellman Family Award (2002), and the UCSF Creativity Award (2001).
Eduardo J. Caceres, B.S. Laboratory Manager
Eduardo Caceres has more than 10 years of experience in cell and tissue culturing and managing a Safety Level II laboratory. In 2005, he joined StemLifeLine after serving as a research assistant and laboratory manager for the University of California, San Francisco where he honed his skills in stem cell derivation and culture. At UCSF, Caceres was a part of the team that derived embryonic stem cells on human feeders, led by StemLifeLine’s Executive Board president, Dr. Olga Genbacev.
Caceres was awarded the UCSF Staff Performance Award, Department of Cell & Tissue Biology in 2001 and 2002. He holds a bachelor’s of science from the University of California, Santa Cruz.
